Red Spruce Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
AAMU
CRM
SP
ORIO
CNB
Red Spruce Capital's MRK Position: Q2 2026 in Review
Red Spruce Capital increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $40.6K and bringing the position to 26,440 shares worth $3.4M. The position accounts for 1.18% of the portfolio, ranked #27.
Red Spruce Capital first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.7M in Q4 2022. 821 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Red Spruce Capital held 26,440 shares of Merck worth $3.4M as of Q2 2026.
- Red Spruce Capital bought 347 Merck shares in Q2 2026, an estimated $40.6K.
- Merck made up 1.18% of Red Spruce Capital's portfolio in Q2 2026, its #27 holding.
- Red Spruce Capital first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
- Red Spruce Capital's Merck position peaked at $5.7M in Q4 2022.
- 821 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Red Spruce Capital's 13F filing for Q2 2026, filed 7 Jul 2026.